Includes nasal sprays in topical therapeutic pharmaceutical agents optometrists are authorized to use

This bill expands the range of medications optometrists can prescribe by officially including nasal sprays as topical therapeutic agents. Specifically, it allows eye doctors to use nasal sprays to treat dry eye disease, which is currently not covered under their existing authority. The change updates the Education Law to clarify that drugs administered via nasal spray fall under the same category as other topical treatments for eye conditions. Once enacted, this provision takes effect immediately, enabling optometrists to offer this specific treatment option to patients.